![logo](/logos/MYX.AX.webp)
Mayne Pharma Group Limited
ASX:MYX.AX
4.5 (AUD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Mayne Pharma Group Limited |
Symbool | MYX.AX |
Munteenheid | AUD |
Prijs | 4.5 |
Beurswaarde | 382,834,350 |
Dividendpercentage | 0% |
52-weken bereik | 2.75 - 7.46 |
Industrie | Drug Manufacturers—General |
Sector | Healthcare |
CEO | Mr. Shawn Patrick O'Brien B.Sc |
Website | https://www.maynepharma.com |
An error occurred while fetching data.
Over Mayne Pharma Group Limited
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products. It provides oral drug delivery systems; and contract
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (AUD)
Cijfers zijn in miljoenen (AUD)